Navigation Links
diaDexus, Inc. Reports 2011 First Quarter Financial Results
Date:5/16/2011

isease and ischemic stroke associated with atherosclerosis. For more information, please visit the company's website at www.diaDexus.com.

Forward-Looking StatementsThis news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the company's plans, objectives, expectations and intentions with respect to future operations and products and other statements that are not historical in nature, particularly those that use terminology such as "will," "potential", "could," "can," "believe," "intends," "continue," "plans," "expects," "projects," "estimates" or comparable terminology. Forward-looking statements are based on current expectations and assumptions, and entail various known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Important factors known to diaDexus that could cause actual results to differ materially from those expressed in such forward-looking statements include diaDexus' ability to maintain regulatory clearance for and successfully commercialize its PLAC Tests and new diagnostic products, including its enhanced PLAC TIA test; diaDexus' reliance on sole source third party manufacturers to manufacture and supply our main reagent and the PLAC Test; the company's relationships with key customers; the effects of government regulations and the company's ability to comply with such regulations; diaDexus' ability to demonstrate that treatment of individuals based on their Lp-PLA2 levels improves clinical outcomes in prospective clinical studies; the rate of adoption of the PLAC Test by doctors and laboratories; the third party payor's acceptance of and reimbursement for the PLAC Test; diaDexus' ability to retain key employees and to attract, retain and motivate other qualified personnel;
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
2. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 ... a provider of advanced cancer genome analysis and ... leader in discovering and developing highly selective kinase ... first-ever comprehensive genomic study of malignant mixed Mullerian ... the female reproductive system, also known as carcinosarcoma. ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Delivers Unprecedented Specificity for ... Diagnosing ... Medical Solutions,Diagnostics (http://www.siemens.com/diagnostics ) announced that it has ... rights to develop an,automated stimulating TSH receptor antibody (TRAb) ...
... more effective than,tamoxifen at preventing breast cancer recurrence ... with hormone-responsive cancers. In addition, the increased,risk of ... being treated with,anastrozole disappears after treatment ends., ... Antonio Breast Cancer,Symposium, Professor John Forbes of the ...
Cached Medicine Technology:Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu 2Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu 3Anastrozole Confirmed Superior in Breast Cancer Prevention 2
(Date:9/21/2014)... 21, 2014 According to latest National ... birth rate since 1966 (10.5 births per 1,000 women in ... 40s has risen steadily by 2 percent per year. The ... women aged 50 and over) also rose, the first such ... more than nine times as many first births to women ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Diabetes ... Kenneth Pullman that is helping thousands of people learn ... symptoms without shots, pills, or prescriptions has caught the ... , “There are currently tens of millions of people ... 1 and Type 2 diabetes, and unfortunately, big pharma ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Villa ... Villa del Palmar Cabo San Lucas, Villa La Estancia ... to Hurricane Odile, with plans to welcome guests back ... As of Sept. 19, all members and guests of ... thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... September 20, 2014 Ticket Down ... concert tickets. This popular ticket exchange is offering their ... Grande is nearing that next step in the entertainment business. ... superstar in the music and entertainment business, but is closing ... second straight No. 1 album, will hit the road next ...
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new ... exam life insurance plan provides for vulnerable family members. ... should be a top priority for every provider. It ... taking medical examinations and visiting a doctor. , ... will provide coverage up to $300,000, but only to ...
Breaking Medicine News(10 mins):Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2
... we deal with death are finding a new life online, ... journalism professor and her colleague. "You,re accustomed to clipping ... family Bible, but with online obituary services you can e-mail ... of journalism and mass communications at K-State. She and ...
... Receive Up to $400,000 in Funding - Application Deadline ... 16 The GlaxoSmithKline IMPACT Awards target community-based nonprofits ... Up to ten organizations in Berks, Bucks, Chester, Delaware, ... $40,000 each. The awards are bestowed upon winning ...
... Doctor Diabetic Supply, Inc., one of the nation,s leading ... proud to announce that it has acquired Diabetes Source ... acquisition is an important step in the execution of ... Rx will be easily integrated into the Doctor Diabetic ...
... , "Jen,s Story" is a riveting 60-second TV spot depicting ... breast cancer breakthroughs , , WASHINGTON, June 16 ... spot "Jen,s Story" has won four Telly Awards in the ... Awards is the premier award honoring outstanding local, regional, and ...
... 16 Particle Sciences Inc., a leading service ... Products (drug-eluting devices), has further expanded their development ... a Leistritz ZSE-18mm twin screw compounding extruder. This ... line that is suitable for the preparation of ...
... stress , TUESDAY, June 16 (HealthDay News) -- U.S. health ... cold remedy products because they can cause the loss of ... the warning include Zicam Cold Remedy Nasal Gel, Zicam Cold ... , "These products claim to reduce the duration of the ...
Cached Medicine News:Health News:Online obituaries are changing the way we publicly remember the dead and how newspapers cover deaths 2Health News:Online obituaries are changing the way we publicly remember the dead and how newspapers cover deaths 3Health News:GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare 2Health News:Doctor Diabetic Supply, Inc. Acquires Diabetes Source Rx 2Health News:Breast Cancer TV Spot Wins Four Telly Awards 2Health News:Particle Sciences Further Expands Combination Product Development Capabilities 2Health News:FDA Issues Warning for Over-the-Counter Cold Remedy 2Health News:FDA Issues Warning for Over-the-Counter Cold Remedy 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: